Variable | Overall n = 340 | Isolated hypercholesterolemia n = 137 | Mixed dyslipidemia n = 203 | P |
---|---|---|---|---|
Sex (female) | 221 (65.0) | 105 (76.6) | 116 (57.1) | < 0.001 |
Age (years) | 47.0 (35.0–58.0) | 43.0 (32.0–57.0) | 48.0 (37.0–58.0) | 0.019 |
Type 2 Diabetes (%) | 65 (19.1) | 10 (7.3) | 55 (27.1) | < 0.001 |
Hypertension (%) | 70 (20.6) | 21 (15.3) | 49 (24.3) | 0.046 |
Total cholesterol (mg/dL) | 209.0 (179.0–241.5) | 179.0 (160.0–198.8) | 226.5 (206.0–266.8) | < 0.001 |
HDL cholesterol (mg/dL) | 42.0 (35.0–48.8) | 47.0 (41.0–54.0) | 38.0 (33.0–44.0) | < 0.001 |
Non-HDL cholesterol (mg/dL) | 168.0 (133.0–198.0) | 129.5 (112.0–154.8) | 188.0 (168.3–227.0) | < 0.001 |
Triglycerides (mg/dL) | 182.5 (107.3–310.3) | 99.0 (73.0–122.3) | 271.0 (205.5–394.8) | < 0.001 |
Apolipoprotein B (mg/dL) | 116.0 (90.0–136.8) | 87.0 (72.9–103.8) | 128.5 (114.3–148.8) | < 0.001 |
VLDL-Triglycerides (mg/dL) | 120.8 (61.3–240.1) | 54.7 (34.0–73.9) | 211.0 (144.2–329.9) | < 0.001 |
VLDL-Cholesterol (mg/dL) | 32.4 (16.5–52.5) | 14.7 (9.1–19.7) | 49.0 (36.1–67.4) | < 0.001 |
VLDL-Cholesterol Martin (mg/dL) | 32.9 (21.3–46.0) | 19.7 (16.0–22.9) | 43.5 (34.5–56.4) | < 0.001 |
VLDL-Cholesterol Sampson (mg/dL) | 35.1 (18.6–54.4) | 16.5 (12.0–20.9) | 51.6 (37.8–69.7) | < 0.001 |
VLDL-Cholesterol Friedewald (mg/dL) | 36.5 (21.5–62.1) | 19.8 (14.6–24.5) | 54.2 (41.1–79.0) | < 0.001 |
LDL-Cholesterol (mg/dL) * | 127.7 (106.4–151.6) | 114.2 (98.4–136.9) | 139.0 (119.4–161.7) | < 0.001 |
LDL-cholesterol Martin (mg/dL) | 130.1 (106.2–151.4) | 109.4 (95.0–131.4) | 142.9 (121.5–162.3) | < 0.001 |
LDL-Cholesterol Sampson (mg/dL) | 127.8 (101.1–145.8) | 111.8 (95.6–133.1) | 134.6 (110.7–157.5) | < 0.001 |
LDL-Cholesterol Friedewald (mg/dL) | 122.6 (97.2–142.4) | 109.4 (94.4–130.9) | 128.8 (102.1–153.5) | < 0.001 |
Statin treatment (%) | 41 (12.0) | 5 (3.6) | 36 (17.7) | < 0.001 |